Latest Tag: Biosafety Resources

UPDATE: After nine years of arduous litigation by the ACB, a full bench of the Supreme Court of Appeal on 22 October 2024 set aside several layers of decision-making regarding the approval of the application by Monsanto, now Bayer, for commercial release of its drought-tolerant genetically modified maize, MON87460. 28 June 2023 UPDATE: In 2023, […]

– By ACB Research and Advocacy Officer Sabrina Masinjila & Executive Director Mariam Mayet For several years, the ACB has engaged at multiple levels with the development of the Post-2020 Global Biodiversity Framework (GBF). In the lead up to the Convention on Biological Diversity (CBD) Conservation’s fifteenth Conference of Parties (COP 15), held in Montreal, Canada in […]

– A blog by ACB Director Mariam Mayet Snapshot In October 2021, the South African (SA) government determined that the regulatory and risk assessment framework that exists for genetically modified organisms (GMOs) will also apply to new breeding techniques (NBTs), which make up a host of new genetic engineering technologies. This decision appears to follow […]

The news that the Swaziland Environmental Authority (SEA) had authorised the importation and commercial release of Bt cotton seeds came as a huge shock to the African Centre for Biodiversity (ACB). It meant that ACB had to reconsider its earlier acceptance of an invitation by SEA to attend a National Biosafety Indaba on 22 May […]

At the negotiations for the Biosafety Protocol in Cartagena, the South Africa government surprised critics by displaying a maturity and understanding of the issues and concerns facing developing countries on the question of genetically engineered organisms. This in spite of attempts by the ‘Miami group’, a negotiating group representing the largest producer nations of biotechnology, […]